Stage I cholelithiasis. Approaches to diagnosis and treatment. Results of the Machaon study
Authors:
Open Access
- 26 March 2025
- journal article
- research article
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 97 (2) , 137-144
Abstract
Aim. To review the results of the open observational study Makhaon on the use of a fixed combination of glycyrrhizic acid (GA) and ursodeoxycholic acid (UDCA) (Phosphogliv Urso) for the treatment of abdominal pain, assessment of contractile function of the gallbladder and bile rheology in patients with stage I cholelithiasis. Materials and methods. The study included 330 subjects, 44.5% males and 55.5% females. The study participants were 18–70 years old, with a mean age of 43.8±0.6 years. In 2021–2022, patients were treated in 14 clinical centers in 10 cities of the Russian Federation: Moscow, St. Petersburg, Stavropol, Volgograd, Perm, Samara, Ufa, Omsk, Novosibirsk, Tomsk. All patients received Phosphogliv Urso (UDCA 250 mg + sodium glycyrrhizinate 35 mg), 1 capsule 3 times daily with food for 6 months. Results. Based on the clear improvement, therapy with a combination of GA and UDCA has demonstrated high efficacy and safety and appears to be optimal for the treatment of abdominal pain, improvement of the contractile function of the gallbladder, and physicochemical properties of bile in patients with stage I cholelithiasis. Conclusion. Treating all variants of baseline changes in the bile rheology is an urgent task of modern biliology. Universal drugs for stage I cholelithiasis are UDCA and its fixed combination with GA.Keywords
This publication has 17 references indexed in Scilit:
- Glycyrrhizic acid as a multifunctional drug carrier – From physicochemical properties to biomedical applications: A modern insight on the ancient drugInternational Journal of Pharmaceutics, 2019
- EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstonesJournal of Hepatology, 2016
- Gallbladder and Sphincter of Oddi DisordersGastroenterology, 2016
- Long-term Outcomes of Symptomatic Gallbladder SludgeJournal of Clinical Gastroenterology, 2015
- Obesity and the risk and prognosis of gallstone disease and pancreatitisBest Practice & Research Clinical Gastroenterology, 2014
- Endoscopic Ultrasound and Magnetic Resonance Cholangiopancreatography in Patients with Idiopathic Acute PancreatitisDigestive Diseases and Sciences, 2013
- Hepatic insulin resistance directly promotes formation of cholesterol gallstonesNature Medicine, 2008
- Ursodeoxycholic acid — adverse effects and drug interactionsAlimentary Pharmacology & Therapeutics, 2003
- Bile lithogenicity and gallbladder emptying in patients with microlithiasis: Effect of bile acid therapyGastroenterology, 1998
- Efficacy of bile acid therapy for gallstone dissolution: a meta‐analysis of randomized trialsAlimentary Pharmacology & Therapeutics, 1993